- Home
- LGO vs GNLX Comparison
LGO vs GNLX Comparison
Compare LGO & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LGO | GNLX |
|---|---|---|
| Founded | 1988 | 2001 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.6M | 113.6M |
| IPO Year | 2007 | 2022 |
Fundamental Metrics
Financial Performance| Metric | LGO | GNLX |
|---|---|---|
| Price | $1.17 | $2.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $3.25 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 1.0M | 185.6K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,000.00 |
| Revenue This Year | $50.56 | N/A |
| Revenue Next Year | $59.94 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.85 | $2.29 |
| 52 Week High | $2.70 | $8.54 |
Technical Indicators
Market Signals| Indicator | LGO | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 58.31 |
| Support Level | $1.07 | $2.33 |
| Resistance Level | $1.25 | $2.97 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 20.41 | 72.55 |
Price Performance
Historical ComparisonAbout LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.